Healthtech Startups

IbisVision provides a digital platform for eye care practices that includes online vision checks and remote patient monitoring to facilitate digital patient journeys. The platform enables eye care providers to attract, engage, and support patients across connected care pathways.

1 investor

Move AI is an AI-powered route optimization platform for non-emergency medical transportation (NEMT) providers, brokers, and managed care organizations. It automates trip planning, driver assignment, and real-time routing using Google Fleet Engine to reduce costs and improve operational efficiency.

1 investor

iCAD develops FDA-cleared, AI-based solutions for breast cancer detection, breast density assessment, and risk evaluation, used by radiologists in mammography workflows. Its offerings support 2D and 3D digital breast tomosynthesis screening to aid earlier cancer detection.

1 investor

Icon Bioscience develops biodegradable, sustained-release intraocular ophthalmic products using its proprietary Verisome drug delivery technology, targeting unmet needs in inflammation, glaucoma, and retinal disease treatment.

1 investor

Iconovo develops advanced inhaler platforms and dry powder formulations optimized together to deliver medicines through inhalation across multiple therapeutic areas. The company partners with pharmaceutical manufacturers to create effective alternatives to tablets and injections, generating revenue through development partnerships, milestone payments, and royalties.

1 investor

ICON plc is a global Contract Research Organization providing consulting and outsourced development services to pharmaceutical, biotechnology, medical device, and government organizations to accelerate drug and device development. The company supports clients across all phases of clinical development with integrated services spanning study design, patient recruitment, digital trial solutions, and commercialization.

1 investor

ICU Vision Care develops digital therapeutics for pediatric strabismus (crossed eyes), with plans to pursue FDA approval and eventual myopia management capabilities. The company operates vision care centers and provides customized vision examinations by specialized optometrists.

1 investor

Idea Evolver provides services to pharma, biotech, and life sciences companies, focused on improving brand visibility across search and AI-generated results and on building technology-assisted ACNU (Additional Condition for Nonprescription Use) programs. It helps brands manage patent expirations and scale consumer access to nonprescription care, covering feasibility, clinical studies, and commercialization.

1 investor

Ideal Option operates office-based outpatient clinics providing medication-assisted treatment for opioid, alcohol, and other substance addictions across the United States. It serves patients seeking addiction recovery through a network of 80+ Joint Commission-accredited clinics and an in-house laboratory, accepting Medicaid, Medicare, and self-pay.

1 investor

Ideal Option provides office-based, medication-assisted outpatient treatment for addiction to opioids, alcohol, and other substances, operating clinics that function like primary care settings. It serves patients across the United States, accepting all insurance types including Medicaid and Medicare as well as self-pay.

1 investor

Identifeye provides a fundus imaging platform combining a portable camera device and cloud-based portal software for retinal screening in point-of-care settings. The system serves healthcare providers and clinics conducting diabetic retinopathy and other retinal disease screenings.

1 investor

IDmelon provides passwordless authentication using proximity badges and FIDO2 passkeys for healthcare organizations, enabling fast and secure access to clinical devices and applications without traditional passwords or complex MFA solutions.

1 investor

iDose TR is a procedural pharmaceutical implant that delivers travoprost therapy to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The implant uses a proprietary membrane with nanoporous material for controlled drug delivery as an alternative to daily eye drops.

1 investor

iECURE is a clinical-stage biotechnology company developing in vivo genome editing therapies that insert a functional copy of a gene into a patient's genome to treat rare, life-threatening genetic diseases in children. Its initial focus is on neurometabolic and urea cycle disorders, including ornithine transcarbamylase (OTC) deficiency.

1 investor

ieso develops AI-powered mental health support that integrates into existing healthcare platforms to treat anxiety and depression alongside chronic conditions. The platform targets healthcare providers, behavioral health platforms, and health plans seeking to improve care outcomes and reduce costs.

1 investor

A medical AI company that builds diagnosis and treatment reasoning systems, smart hospital and healthcare platforms, and AI health hardware such as hearing aids and blood pressure monitors. Its products serve hospitals, primary care providers, and patients, including AI diagnostic assistants, intelligent triage, chronic disease management, and an AI health assistant.

1 investor

IFM Therapeutics develops small-molecule drugs that target the innate immune system to treat inflammation-driven diseases and cancer. The company operates through independently financed R&D subsidiaries, each advancing programs aimed at key control nodes of innate immunity such as NLRP3 and cGAS/STING.

1 investor

iFocus Health provides a data-driven digital health platform that helps patients and caregivers make informed treatment decisions for ADHD, combining AI, bioinformatics, and clinical expertise to improve treatment outcomes.

1 investor

IFP Labs operates an integrated network of accredited analytical laboratories in Germany and the UK providing food safety testing, contaminant analysis, and regulatory compliance services. Services span chemical, physical, and microbiological testing for food, feed, water, environmental, and pharmaceutical samples, including nutritional profiling, allergen testing, and label compliance.

1 investor

Galenico is a CDMO (contract development and manufacturing organization) that develops and produces liquid, semi-solid, and solid pharmaceutical forms, covering formulation development, stability studies, manufacturing, filling, and packaging. It serves the medical device, cosmetics, and food supplement sectors, operating under Good Manufacturing Practices with production based in Portugal.

1 investor

Igea Medical develops and manufactures medical devices that use reversible electroporation to treat tumors (electrochemotherapy) and vascular malformations (electrosclerotherapy). The company sells and rents its devices to healthcare providers, based in Italy.

1 investor

IGNIA is a venture capital fund founded in 2007 that invests in early-stage startups solving problems in emerging markets, with a focus on Latin America market expansion. The fund serves as a bridge for regional startups pursuing international growth and for global startups entering Latin America.

1 investor

IGS develops imaging and visualization technology based on inverse scattering theory to enable observation of previously invisible structures and phenomena. The company applies this core technology to solve problems in medical imaging, energy, infrastructure, and security sectors.

1 investor

Clinical Medical Services provides durable medical equipment, home health care, respiratory equipment, inhalation medications, home infusion services, and orthotics and prosthetics to patients across Puerto Rico through an integrated healthcare delivery system.

1 investor